Biotech Values

[walldiver]

I think two questions important to find answers to for any cancer vaccine are:

1. How soon after agreeing to the treatment does the patient receive the product? With Provenge it is 48-72 hours

2. Is the vaccine autologous or allogenic? Provenge is autologous

I think these are two significant advantages for Provenge in any head-to-head survival study with another vaccine, if Provenge is first to market.